Thomas Patrick Kelly
Thomas Patrick Kelly has made 1 open-market purchase worth $560k since Oct 1, 2026, in 1 company. The latest: $560k of XENE, filed Oct 1, 2026, scored 73 out of 100.
CFO, Xenon Pharmaceuticals Inc.
Follow Thomas Patrick Kelly, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 1 Form 4 (opens sec.gov) |
XENEXenon Pharmaceuticals Inc. · CFOCFO · 2 insiders buying · Near 52-week low | New position | 73 | $560k 15,000 at $37.32 |
−7.1% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −7.1% (0% up, 1 measured).
Questions
What stock has Thomas Patrick Kelly bought?
XENE (Xenon Pharmaceuticals Inc.), all on the open market and reported on SEC Form 4.
When did Thomas Patrick Kelly last buy?
Oct 1, 2026: 15,000 shares of XENE at $37.32, $560k in all (Form 4 (opens sec.gov)).
Has Thomas Patrick Kelly filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Thomas Patrick Kelly a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 1, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer